Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01308099 · ClinicalTrials.gov registry record
Assessment of Vascular Endothelial Function in Postural Tachycardia Syndrome
A clinical trial of Postural Tachycardia Syndrome, sponsored by Vanderbilt University Medical Center.
- Completed
- Registry status
- 26
- Enrollment target
- 2
- Study locations
NCT01308099: Completed study of Postural Tachycardia Syndrome, sponsored by Vanderbilt University Medical Center.
NCT01308099 is a study of Postural Tachycardia Syndrome that has completed, run by Vanderbilt University Medical Center. The registered enrollment target is 26 participants, below the 81-participant average among 19 other Postural Tachycardia Syndrome trials with a reported enrollment target (68% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01308099, a study of Postural Tachycardia Syndrome, has completed, sponsored by Vanderbilt University Medical Center.
- COMPLETED
- Registry status
- 26 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this study is to see if people with Postural Tachycardia Syndrome (POTS) have different levels of certain chemicals in their blood than people who don't have POTS. This study will test whether the blood vessels of people with POTS will react differently to certain tests than people without POTS. The hypothesis of the study is: Patients with POTS will have vascular endothelial dysfunction compared with control subjects.
Primary Outcome
The primary analysis of RH-PAT will involve a non-parametric, Mann Whitney U test of RH-PAT between POTS patients and Control subjects.
Conditions Studied
Interventions
- DEVICE Blood Pressure and Blood Flow
Study Locations (2)
Tennessee
- Vanderbilt University Medical Center - Nashville
- Vanderbilt University - Nashville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2011-02 |
| Est. Completion | 2017-01 |
What the finished NCT01308099 record still lists
NCT01308099 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 26 participants, a relatively small participant target, below the 81-participant average among 19 other Postural Tachycardia Syndrome trials with a reported enrollment target (68% lower).
The record links to 1 condition, with Postural Tachycardia Syndrome appearing as the primary indexed condition, and to 1 intervention - of which Blood Pressure and Blood Flow is the first listed.
NCT01308099 reports a single indexed study location in Tennessee.
Frequently Asked Questions
What is clinical trial NCT01308099 about?
NCT01308099 is a clinical study titled "Assessment of Vascular Endothelial Function in Postural Tachycardia Syndrome". The purpose of this study is to see if people with Postural Tachycardia Syndrome (POTS) have different levels of certain chemicals in their blood than people who don't have POTS. This study will test whether the blood vessels of people with POTS will react differently to certain tests than people wi...
What is the current status of trial NCT01308099?
This trial is currently completed. The enrollment target is 26 participants. The study started on 2011-02. Estimated completion is 2017-01.
What conditions does trial NCT01308099 study?
This clinical trial studies the following conditions: Postural Tachycardia Syndrome.
What interventions are being tested in trial NCT01308099?
The interventions under investigation include: Blood Pressure and Blood Flow (DEVICE).
Who is sponsoring clinical trial NCT01308099?
This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01308099 being conducted?
This trial has 2 study locations across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Postural Tachycardia Syndrome
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01308099's enrollment target sits among peer trials
26 16th of 19 higher than 4 of 19 other Postural Tachycardia Syndrome trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Postural Tachycardia Syndrome trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Periaqueductal Gray-vagus Nerve Interface Malfunction Explain the Natural History With Its Numerous Co-morbidities?
RECRUITING · NA
-
Inappropriate Sinus Tachycardia Registry
RECRUITING
-
Autoimmune Basis for Postural Tachycardia Syndrome
RECRUITING · NA
-
A Study of Pyridostigmine in Postural Tachycardia Syndrome
RECRUITING · Phase 2
-
Intravenous (IV) Saline and Exercise in Postural Tachycardia Syndrome (POTS)
ACTIVE NOT RECRUITING · NA
-
Acute Salt Handling in Orthostatic Intolerance
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02646475 · 26 participants · Phase 1
Metabolic Effects of Angiotensin-(1-7)
- NCT03603223 · 26 participants · Phase 2
Pembrolizumab in Treating Participants With Leukoplakia
- NCT04063592 · 26 participants · NA
AMI Construction in Lower Extremity Residual Limbs
- NCT04906460 · 26 participants · Phase 1
Open-label Study of WVE-N531 in Patients With Duchenne Muscular Dystrophy (FORWARD-53)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia